Gilde Healthcare Partners raises growth capital fund dedicated to healthcare services - Gilde Healthcare

Menu
Menu
Home

Gilde Healthcare Partners raises growth capital fund dedicated to healthcare services

8 december 2009

Utrecht, The Netherlands – Gilde Healthcare Partners (Gilde), a European private equity firm specializing in healthcare, today announced the launch of a new growth capital fund, Gilde Healthcare Services. The fund will invest in specialized clinics, providers of elderly care, prevention, screening and other fast growing healthcare services in The Netherlands and surrounding countries. The fund addresses the shortfall in bank finance in the healthcare sector and will provide growth capital to fast growing healthcare services companies. Apart from the new fund, dedicated to healthcare services, Gilde manages two healthcare technology funds.

Gilde Healthcare Services is one of the few European private equity funds raised in 2009. The fund is backed by a mix of institutional investors, family offices and private investors. Gilde is in advanced talks with additional investors and expects the fund size to exceed EUR 50 million in the course of 2010.

“We believe this successful fundraising in the current economic climate is a validation of our strategy. With our hands-on, specialized investment approach we will facilitate the growth of a variety of healthcare service companies.”

said Jasper van Gorp, Investment Director.

“The healthcare sector is transforming rapidly and via Gilde Healthcare Services we provide investors a unique opportunity to participate in fast growing healthcare services.”

About Gilde Healthcare Partners

Gilde Healthcare Partners is headquartered in Utrecht, The Netherlands and manages EUR 300 million (USD 450 million) in three investment funds. Gilde’s healthcare technology funds, Healthcare I and II, invest venture capital in therapeutics, diagnostics, medical technologies and biotech. The newly raised Gilde Healthcare Services I fund provides growth capital to healthcare services companies. Gilde Healthcare Partners is a successful builder of healthcare businesses across Europe. By investing in companies with clear deliverable business models, Gilde applies its financial resources, partner expertise and business network to create significant value for both its investors and the entrepreneurs it backs.

Contact
Gilde Healthcare Partners
Jasper van Gorp
Investment Director Healthcare Services
+31(0)30-2192528
vangorp@gildehealthcare.com
www.gildehealthcare.nl

Meer nieuws

Gilde Healthcare company Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Anthem Blue Cross/Blue Shield

Mainstay Medical Holdings plc today announced that Anthem Blue Cross and Blue Shield (“Anthem”) has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. ReActiv8...
28 april 2025

Gilde Healthcare company Tagworks Pharmaceuticals Announces FDA Clearance of IND Application and Initiation of Phase 1 Clinical Trial for TGW101

TGW101 is a next-generation, first-in-class ADC targeting TAG-72 with an MMAE payload, developed based on Tagworks proprietary Click-to-Release linker chemistry; TGW101 is the first bioorthogonal, in vivo click chemistry-activated ADC, which enables superior control of...
22 april 2025

Gilde Healthcare company SynOx Therapeutics announces Board Chair transition to align with advancing Regulatory and Commercialization Strategy

SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing of emactuzumab for Tenosynovial Giant Cell Tumours (TGCT), today announced the execution of a planned and orderly transition of its board chair position. Philip Astley-Sparke...
1 april 2025